tremor, unsteady wide-based gait, and dysdiadochokinesia with normal cognition.
INTRODUCTION
Paraneoplastic syndromes are a constellation of symptoms and signs that are mediated by substance excreted by tumor cells or by an immune response against the tumor that cross-react with other normal cells. Solitary fibrous tumor (SFT) is associated with multiple paraneoplastic syndromes, including refractory hypoglycemia, hypertrophic pulmonary osteoarthropathy, and elevated beta human chorionic gonadotropin. [1, 2] This is a case of SFT associated with hypoglycemia, neurologic disorder, and possible hypertrophic pulmonary osteoarthropathy.
CASE REPORT
A 60-year-old male with hypertension presented with slurred speech. As per family, the patient was last seen normal 4 days back. He was found in bed covered in feces and urine and was unable to talk properly; he was admitted for the possible cerebral vascular accident. His physical examination was only remarkable for reduced air entry on the left lower lobe and clubbing of the fingers. Neurological examination was notable for staccato speech, intention Solitary fibrous tumor (SFT) is a rare mesenchymal tumor and several paraneoplastic syndromes have been related to it. We report the case of a 60-year-old male initially admitted to rule out cerebral vascular accident with the final diagnosis of SFT associated with paraneoplastic cerebellar degeneration and hypoglycemia. The diagnosis was confirmed by computed tomography-guided lung biopsy. This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. Table 1 ]. Blood sugar was stabilized with octreotide subcutaneous injection and dextrose oral gel. Paraneoplastic cerebellar degeneration was suspected and antibodies were sent; anti-Hu, anti-Yo, and anti-Ri were negative. After a lengthy discussion with the patient, the patient was transferred to the rehab facility to improve his functional status before surgery.
DISCUSSION
SFT is a rare mesenchymal tumor. The standardized incidence rate is estimated to be 1.4 per million and the malignancy rate is estimated to be 13%-37%. [3, 4] Malignant SFP showed high cellular pleomorphism, high mitotic activity, increased cellularity, necrosis, and hemorrhage. [5] Our case was likely a malignant tumor based on size and the presence of necrosis. It is difficult to diagnose SFT on radiological imaging, and the sensitivity of CT is low. [1] The diagnosis is confirmed by histopathology with immunohistochemistry staining. STAT6, a very sensitive and specific marker for SFT, was used for diagnosis in this case. [1, 6] Pa r a n e o p l a s t i c s y n d r o m e s s u c h a s r e f r a c t o r y hypoglycemia (Doege-Potter syndrome [DPS]) and hypertrophic pulmonary osteoarthropathy such as clubbing have been reported with SFT. [1, 2] DPS was first described in 1930 with an estimated incidence of 3%-4%. [1, 7] Large tumor size and high mitotic rate are often related to hypoglycemia. [8] Meng et al. reported an equal incidence of benign and malignant SFT associated with hypoglycemia; however, tumor larger than 10 cm had a higher incidence of hypoglycemia. [9] It has been reported that in a patient with SFT, there is an increase in the prohormone to IGF2 which acts to regulate normal glucose concentration in the serum. [10] Since this is not measured in the routine laboratory test, a surrogate to this rise in this prohormone (also known as the big-IGF2) is the increase in the ratio of IGF2 to IGF1. [10, 11] This is likely the mechanism of hypoglycemia in our case. Other causes include hepatic or adrenal cancerous destruction.
The resolution of hypoglycemia usually occurs after tumor resection. Intravenous glucose administration, glucagon infusion, glucocorticoids, growth hormone, or octreotide can be tried before surgery. [12] Although Perros et al. reported persistent hypoglycemia despite maximal doses of octreotide treatment, [13] our case showed improved glucose levels after octreotide subcutaneous injection.
The onset of neurological symptoms often precedes the identification of the tumor and the recognition of a paraneoplastic syndrome should lead to an immediate search for cancer. [14, 15] In our case, the patient had chronic fasting hypoglycemia which symptoms can mimic a stroke. Paraneoplastic Syndrome is caused by autoimmune process and several antibodies have been used to facilitate the diagnosis. [16] Some patients have no identifiable antibodies in their serum as our patient. However, the absence of antibodies cannot rule out the diagnosis. Unlike DPS which symptoms resolve after tumor resection, cerebellar symptoms usually partial or complete remission after treating primary cancer.
CONCLUSION
SFT is rare cancer and is sometimes associated with multiple paraneoplastic syndromes. It is associated with multiple paraneoplastic syndromes. This is the first case that presented with neurological disorder and hypoglycemia. Further research is needed to determine the treatment option in the future.
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